Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer

"Getting From Here to There"-Mechanisms and Limitations to the Activation of the Androgen Receptor in Castration-Resistant Prostate Cancer

(2016) Nima Sharifi et al.   JOURNAL OF INVESTIGATIVE MEDICINE

The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders

(2011) Walter L. Miller et al.   ENDOCRINE REVIEWS

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

3β-Hydroxysteroid Dehydrogenase Is a Possible Pharmacological Target in the Treatment of Castration-Resistant Prostate Cancer

(2010) Kristen Evaul et al.   ENDOCRINOLOGY

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

(2010) Howard I Scher et al.   LANCET

Androgen biosynthetic pathways in the human prostate

(2008) Van Luu-The et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer

(2008) J. A. Locke et al.   CANCER RESEARCH

Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

(2008) R. B. Montgomery et al.   CANCER RESEARCH

Phase II Study of Dutasteride for Recurrent Prostate Cancer During Androgen Deprivation Therapy

(2008) Satyan K. Shah et al.   JOURNAL OF UROLOGY

Pre-receptor regulation of the androgen receptor

(2007) Trevor M. Penning et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY